Ajit S. Gill
President & Chief Executive Officer

Ajit Gill is a medical industry veteran with experience developing and commercializing biopharmaceutical products, creating successful partnerships, raising funds, and growing companies from start-ups to publicly traded firms. During his fourteen year tenure at Nektar Therapeutics, the company developed a leading drug delivery technology portfolio, completed over 30 strategic alliances with biopharmaceutical partners, and commercialized products with these partners that account for over $4.5 billion in sales. Since leaving Nektar, Mr. Gill has served as CEO of Auspex Pharmaceuticals and as Entrepreneur-in-Residence for US Venture Partners of Menlo Park, California. Earlier in his career he held a variety of roles including general management, finance, business development and operations in the computer and other industries. Originally from India, Mr. Gill completed his B. Tech in electrical engineering from the Indian Institute of Technology, Kanpur, his MS in electrical engineering from the University of Nebraska and his MBA from the University of Western Ontario.

Robert W. Crane
Chief Financial Officer

Robert Crane is a seasoned executive with strong general management and financial experience who has had involvement at all levels in the starting, building, turnaround and financing of healthcare companies. Bob has extensive experience with public and private companies, corporate partnerships in the U.S. as well as Europe and Japan, fundraising both private and public, sale of companies and product lines as well as the acquisition of companies and technologies. He has been the CFO of several successful healthcare companies as well as a venture capitalist. He earned his MBA from Stanford and his Bachelors from MIT.

Robert Farra
Vice President, Research and Development

Robert Farra has over two decades of leadership experience successfully developing complex electro-mechanical medical devices. Most recently, he served as Vice President of Engineering and Manufacturing for Abiomed, leading the development of intra-aortic balloon pumps and ventricular assist devices. Mr. Farra has also held leadership positions at Accellent Endoscopy and Arthur D. Little, Inc. (ADL) where he led multidisciplinary teams in the development of numerous minimally invasive surgical instruments and interventional devices. Mr. Farra holds a BSME from University of Massachusetts, Lowell and an SMME from MIT. Mr. Farra holds nine domestic and international patents.

Maggie Pax
Vice President of Business Development

Maggie Pax is an experienced medical device executive with a track record of new business creation and market development for innovative medical technologies. At Hewlett-Packard Medical Products Group (now Philips Medical Systems), Maggie held senior roles in marketing, strategic business planning and corporate partnering. As Vice President of Marketing for OmniSonics Medical Technologies, Maggie led market development, product launch, post-market clinical studies and strategic product planning for the company's novel therapeutic peripheral vascular device business. Maggie earned an MBA from Harvard Business School and her Bachelors from the College of the Holy Cross.